Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Clinical Pharmacokinetics|January 1, 1976
Drug protein binding and the nephrotic syndromeR Gugler, D L AzarnoffThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1975
Diphenylhydantoin potency and plasma protein bindingD W Shoeman, D L AzarnoffCancer Research|September 1, 1979
Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drugD J Svoboda, D L AzarnoffClinical Pharmacokinetics|August 1, 1990
Pharmacokinetic investigations in elderly patients. Clinical and ethical considerationsD R Abernethy, D L AzarnoffBiomedical Mass Spectrometry|February 1, 1978
Identification of methotrexate and folic acid analogs by mass spectrometryC E Hignite, D L AzarnoffThe Journal of Pharmacology and Experimental Therapeutics|December 1, 1975
Effect of portacaval shunt on the disposition of drugs with and without first-pass effectR Gugler, P Lain, D L AzarnoffSteroids|March 1, 1976
In vitro inhibition of rat liver cholest-5en-3 beta-ol (cholesterol) biosynthesis by non-mercurial sulfhydryl reagentsD Abernethy, C Hignite, D L AzarnoffKlinische Wochenschrift|May 1, 1975
Diphenylhydantoin: correlation between protein binding and albumin concentrationR Gugler, D L Azarnoff, D W ShoemanThe American Review of Respiratory Disease|June 1, 1977
Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophyllineM Fixley, D D Shen, D L AzarnoffAmerican Journal of Hospital Pharmacy|February 1, 1976
Clinical use of digitalis glycosidesD H HuffmanPageof 9